Studies

Clinical Research conducted on the use of PYNOCARE

PYNOCARE has been approved by the Ministry og Health in many countries including Malaysia, and has been clinically studied by the SpinControl Institute, France and HUKM Malaysia.

These studies prove that PYNOCARE effectively reduces the size and intensity of pigmentation on the face and is safe for human consumption.

Study by the SpinControl Institute, France

Results of a clinical study conducted over a period of 12 weeks yielded the following results: 

1. A 85% efficacy rate in the reduction of the size and intensity of pigmentation.
2. No adverse side effects reported

Study by Hospital Universiti Kebangsaan Malaysia (HUKM) Malaysia

Results of a double-blind, placebo-controlled study conducted over a period of 8 weeks yielded the following results:

1. Overall efficacy rate of 76% in the reduction of the size and intensity of pigmentation
2. No adverse side effects reported

Conclution

PYNOCARE with MSCC Complex Actisome is the first and only natural oral depigmentation solution. It effectively repairs and strengthens the skin from the inside out, visibly reducing the size and intensity of skin pigmentation.

PYNOCARE contains powerful antioxidant and anti-inflammatory properties and is 50 times more potent than Vitamin C & E.

PYNOCARE's natural and safe formulation has also been clinically proven to reduce the size and intensity of pigmentation spots on the face. PYNOCARE treats skin pigmentation at its roots.